Ron Firestein

发表

CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

Pablo Tamayo, Ian F. Dunn, Shuji Ogino, 2008, Nature.

CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency.

Zora Modrusan, Z. Modrušan, A. Adler, 2012, Cancer research.

Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene

Eric S. Lander, Marc Vidal, Ian F. Dunn, 2007, Cell.

Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas

Li Li, William F. Forrest, Laura Deming, 2012, Clinical Cancer Research.

CDK8 expression in 470 colorectal cancers in relation to β‐catenin activation, other molecular alterations and patient survival

Shuji Ogino, W. Hahn, E. Giovannucci, 2010, International journal of cancer.

SIRT1 Histone Deacetylase Expression Is Associated with Microsatellite Instability and CpG Island Methylator Phenotype in Colorectal Cancer

Shuji Ogino, Aditi Hazra, Edward L. Giovannucci, 2009, Modern Pathology.

CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.

Oleg Mayba, Florian Gnad, Ehud Segal, 2016, The Journal of clinical investigation.

CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity

Sridhar Ramaswamy, Eric S. Lander, Ian F. Dunn, 2010, PloS one.

Oncogenic ERBB3 mutations in human cancers.

Somasekar Seshagiri, Jeremy Stinson, Charles Eigenbrot, 2013, Cancer cell.

Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells.

Philippe Bergeron, Kevin R Clark, James R Kiefer, 2016, ACS medicinal chemistry letters.

Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody–Drug Conjugate as a Therapeutic for Non–Small Cell Lung and Ovarian Cancers

Paul Polakis, Keyang Xu, Leslie Roth, 2015, Clinical Cancer Research.